Lipoprotein Metabolism in APOB L343V Familial Hypobetalipoproteinemia

The Journal of Clinical Endocrinology and Metabolism
Amanda J HooperJohn R Burnett

Abstract

Familial hypobetalipoproteinemia (FHBL) is a codominant disorder of lipoprotein metabolism characterized by decreased plasma concentrations of low-density lipoprotein (LDL)-cholesterol and apolipoprotein B (apoB). The objective was to examine the effect of heterozygous APOB L343V FHBL on postprandial triglyceride-rich lipoprotein (TRL) and fasting lipoprotein metabolism. Plasma incremental area under the curve apoB-48 and apoB-48 kinetics were determined after ingestion of a standardized oral fat load using compartmental modeling. Very low-density lipoprotein (VLDL)-, intermediate-density lipoprotein (IDL)-, and LDL-apoB kinetics were determined in the fasting state using stable isotope methods and compartmental modeling. The postprandial incremental area under the curve (0-10 h) in FHBL subjects (n = 3) was lower for large TRL-triglyceride (-77%; P < .0001), small TRL-cholesterol (-83%; P < .001), small TRL-triglyceride (-88%; P < .001), and for plasma triglyceride (-70%; P < .01) and apoB (-63%; P < .0001) compared with controls. Compartmental analysis showed that apoB-48 production was lower (-91%; P < .05) compared with controls. VLDL-apoB concentrations in FHBL subjects (n = 2) were lower by more than 75% compared with hea...Continue Reading

Associated Clinical Trials

References

Jan 1, 1995·Arteriosclerosis, Thrombosis, and Vascular Biology·C A Aguilar-SalinasG Schonfeld
Nov 13, 1999·Arteriosclerosis, Thrombosis, and Vascular Biology·N EliasG Schonfeld
Jan 29, 2003·The Journal of Biological Chemistry·John R BurnettZemin Yao
Sep 2, 2004·American Journal of Physiology. Endocrinology and Metabolism·Lidia S SzczepaniakRobert L Dobbins
Jan 11, 2007·The Journal of Clinical Endocrinology and Metabolism·Amanda J HooperJohn R Burnett
Nov 26, 2010·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·A LozanoJ Lopez-Miranda
Jan 8, 2011·Expert Opinion on Investigational Drugs·Damon A BellJohn R Burnett
May 23, 2013·Clinica Chimica Acta; International Journal of Clinical Chemistry·Liesl V HeeksJohn R Burnett
Apr 23, 2014·Current Opinion in Lipidology·Francine K Welty
May 2, 2014·Current Atherosclerosis Reports·Amanda J Hooper, John R Burnett

❮ Previous
Next ❯

Citations

Feb 27, 2020·PloS One·Paul T Williams
Aug 11, 2020·Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids·Hanna RuhanenVesa M Olkkonen

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.